Voglow GM Voglow 0.3 GM1 Tablet
Marketer
Primus Remedies Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Voglow GM Voglow 0.3 GM1 Tablet
Diabeva Duo 0.3mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This medication helps manage blood glucose levels. Diabeva Duo 0.3mg tablets should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (sugary foods, fruit juice) are vital. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Voglow GM Voglow 0.3 GM1 Tablet
Managing type 2 diabetes
Major Benefits of Voglow GM Voglow 0.3 GM1 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Consume Voglow GM Voglow 0.3 GM1 Tablet on an empty stomach.
Common Side effects of Voglow GM Voglow 0.3 GM1 Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglow GM Voglow 0.3 GM1 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Voglow GM Voglow 0.3 GM1 Tablet on an empty stomach.
How Voglow GM Voglow 0.3 GM1 Tablet works:
One Voglow tablet (0.3 gm) contains a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Voglow GM Voglow 0.3 GM1 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Pregnancy and the use of Voglow GM 0.3 GM1 Tablets may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The administration of Voglow GM, specifically the 0.3 GM1 Tablet formulation, during lactation is likely inadvisable. Preliminary human evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Voglow GM Voglow 0.3 GM1 Tablets, as their use may be unsafe. Medical advice is recommended. The use of Voglow GM Voglow 0.3 GM1 Tablets is particularly discouraged for individuals with severe kidney impairment.
LiverCAUTION
Patients with liver disease should use Voglow GM Voglow 0.3 GM1 Tablet cautiously, as dose modification may be necessary. Consult a physician before use. A low initial dose is generally recommended for those with mild to moderate liver impairment; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Voglow GM Voglow 0.3 GM1 Tablet :
Should you forget a dose of Voglow GM 0.3 GM1 Tablet, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Voglow GM Voglow 0.3 GM1 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently